How Ph.D. was paid
$33.2M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Michael M. Morrissey, Ph.D.President and Chief Executive Officer | $1,306,040 | $30,539,552 | $1,382,591 | $11,000 | $33,239,183 |
| Christopher J. SennerExecutive Vice President and Chief Financial Officer | $822,823 | $9,343,867 | $470,782 | $11,000 | $10,648,472 |
| Dana T. Aftab, Ph.D.Executive Vice President, Research and Development | $659,058 | $9,479,940 | — | $397,250 | $10,547,248 |
| Patrick J. HaleyExecutive Vice President, Commercial | $621,321 | $8,061,792 | $327,303 | $11,000 | $9,021,416 |
| Brenda J. Hefti, J.D., Ph.D.Senior Vice President and General Counsel | $454,545 | $3,451,975 | $286,751 | $11,000 | $4,204,271 |
| Jeffrey J. Hessekiel, J.D.Former Executive Vice President, General Counsel | $672,374 | $8,309,218 | — | $11,000 | $8,992,592 |
| Amy C. Peterson, M.D.Former Executive Vice President, Medical Affairs, and Chief Medical Officer | $614,496 | $8,442,574 | — | $2,088,964 | $11,146,034 |
What changed and why
- $2.32BTotal revenues for 2025 grew 7% year-over-year to $2.32 billion reflecting franchise strength.
- $33.2MChief Executive Officer total compensation increased to $33,239,183 in fiscal 2025 from $12,732,048 in fiscal 2024.
- The board approved a special one-time equity award program to reinforce shared ownership and support retention.
- 97%Approximately 97% of votes cast supported the advisory say-on-pay proposal at the 2025 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.